Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunotoxicol ; 9(4): 339-40, 2012.
Article in English | MEDLINE | ID: mdl-23078377

ABSTRACT

The Immunotoxicology Specialty Section of the Society of Toxicology (SOT) celebrated the 50(th) Anniversary of the SOT by constructing a poster to highlight the milestones of Immunotoxicology during that half-century period. This poster was assembled by an ad hoc committee and intertwines in words, citations, graphics, and photographs our attempts to capture a timeline reference of the development and progressive movement of immunotoxicology across the globe. This poster was displayed during the 50(th) Annual SOT Meeting in Washington DC in March, 2011. The poster can be accessed by any Reader at the SOT Website via the link http://www.toxicology.org/AI/MEET/AM2011/posters_rcsigss.asp#imss. We dedicate this poster to all of the founders and the scientists that followed them who have made the discipline of Immunotoxicology what it is today.


Subject(s)
Allergy and Immunology/trends , Toxicology/trends , Allergy and Immunology/history , District of Columbia , History, 20th Century , History, 21st Century , Humans , Societies, Scientific , Toxicology/history
2.
Toxicol Appl Pharmacol ; 258(1): 99-108, 2012 Jan 01.
Article in English | MEDLINE | ID: mdl-22036726

ABSTRACT

Triclosan is a broad-spectrum antibacterial agent, which has been shown previously to alleviate human allergic skin disease. The purpose of this study was to investigate the hypothesis that the mechanism of this action of triclosan is, in part, due to effects on mast cell function. Mast cells play important roles in allergy, asthma, parasite defense, and carcinogenesis. In response to various stimuli, mast cells degranulate, releasing allergic mediators such as histamine. In order to investigate the potential anti-inflammatory effect of triclosan on mast cells, we monitored the level of degranulation in a mast cell model, rat basophilic leukemia cells, clone 2H3. Having functional homology to human mast cells, as well as a very well defined signaling pathway leading to degranulation, this cell line has been widely used to gain insight into mast-cell driven allergic disorders in humans. Using a fluorescent microplate assay, we determined that triclosan strongly dampened the release of granules from activated rat mast cells starting at 2 µM treatment, with dose-responsive suppression through 30 µM. These concentrations were found to be non-cytotoxic. The inhibition was found to persist when early signaling events (such as IgE receptor aggregation and tyrosine phosphorylation) were bypassed by using calcium ionophore stimulation, indicating that the target for triclosan in this pathway is likely downstream of the calcium signaling event. Triclosan also strongly suppressed F-actin remodeling and cell membrane ruffling, a physiological process that accompanies degranulation. Our finding that triclosan inhibits mast cell function may explain the clinical data mentioned above and supports the use of triclosan or a mechanistically similar compound as a topical treatment for allergic skin disease, such as eczema.


Subject(s)
Anti-Bacterial Agents/pharmacology , Mast Cells/drug effects , Triclosan/pharmacology , Animals , Calcium Ionophores/pharmacology , Cell Degranulation/drug effects , Cell Line, Tumor , Mast Cells/physiology , Rats , Receptors, IgE/physiology
3.
J Appl Toxicol ; 31(3): 231-41, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20842677

ABSTRACT

Millions of people worldwide are exposed to arsenic (As), a toxicant which increases the risk of various cancers, cardiovascular disease and several other health problems. Arsenic is a potent endocrine disruptor, including of the estrogen receptor. It was recently shown that environmental estrogen-receptor disruptors can affect the signaling of mast cells, which are important players in parasite defense, asthma and allergy. Antigen (Ag) or allergen crosslinking of IgE-bound receptors on mast cells leads to signaling, culminating in degranulation, the release of histamine and other mediators. Because As is an endocrine disruptor and because endocrine disruptors have been found to affect degranulation, here we have tested whether sodium arsenite affects degranulation. Using the rat basophilic leukemia (RBL) mast cell model, we have measured degranulation in a fluorescence assay. Arsenic alone had no effect on basal levels of degranulation. However, As strongly inhibited Ag-stimulated degranulation at environmentally relevant concentrations, in a manner that is very dependent on concentrations of both As and Ag. The concentrations of As effective at inhibiting degranulation were not cytotoxic. This inhibition may be a mechanism underlying the traditional Chinese medicinal use of As to treat asthma. These data indicate that As may inhibit the ability of humans to fight off parasitic disease.


Subject(s)
Arsenites/toxicity , Cell Degranulation/drug effects , Endocrine Disruptors/toxicity , Mast Cells/drug effects , Receptors, IgE/drug effects , Sodium Compounds/toxicity , Allergens/immunology , Animals , Antibodies, Monoclonal/pharmacology , Cell Degranulation/physiology , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Antagonism , Drug Therapy, Combination , L-Lactate Dehydrogenase/metabolism , Mast Cells/metabolism , Rats , Receptors, IgE/immunology , Receptors, IgE/metabolism , Trypan Blue/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...